On 24 February 2026, the National Theatre in Iganmu, Lagos, became a convergence point for policymakers, research leaders, funding agencies, and institutional representatives across the country and beyond, committed to strengthening Nigeria’s position within the global research ecosystem.
The Nigeria-EU Science and Innovation Day was a gathering of decision-makers and scientific stakeholders around a central priority—how can Nigeria develop the systems necessary to compete effectively for international research funding while enhancing its global research visibility?
From the opening session to the technical panels and structured matchmaking engagements, the day’s focus was deliberate and solutions-driven. Conversations focused on structure, capacity, and measurable outcomes.
For a long time, many of us in the healthcare ecosystem saw research as something detached from the daily struggle of the clinic or the pharmacy. Listening to Ambassador Gautier Mignot and Doctor Sunday Echono from TETFund, it became clear that research is the only way Nigeria stops being a consumer nation.
The most compelling discussions examined what it takes for national systems to support successful access to international grants.
Panel sessions addressed governance frameworks, institutional accountability, financial transparency, and administrative readiness.
Funding was discussed not simply as allocation, but as infrastructure supported by clear systems and professional grant management capacity.
Participants explored Nigeria’s growing engagement with Horizon Europe and considered how institutions can expand participation across research clusters.
The message throughout the session was consistent. Competitiveness in global funding calls requires preparation, compliance structures, and strong institutional backing.
The dialogue also touched on coordination between ministries and agencies to ensure that research and innovation financing align with international standards and national development priorities.
Science was positioned as a strategic lever for economic growth, health system strengthening, and industrial development.
For stakeholders in the health sector, references to EDCTP3 attracted particular attention. Expanded collaboration within this framework offers a significant opportunity to strengthen clinical research infrastructure, support investigator-led studies, and deepen participation in multinational trials.
Nigeria’s disease burden, research talent, and expanding academic network create strong potential for growth in this space. With structured engagement and institutional investment, the country can increase its contribution to global health research output while improving domestic healthcare systems.
Research was presented as both a scientific pursuit and a driver of economic value. Peer-reviewed publications, research data, intellectual property development, and commercially viable innovation were discussed as indicators of national research maturity.
One of the most action-oriented segments of the day was the structured matchmaking session. Participants received detailed guidance on funding clusters, consortium requirements, and proposal development pathways. Short research pitches created space for focused engagement between Nigerian and European institutions.
The format encouraged partnership building and concrete next steps. The atmosphere reflected intent to move from networking to structured collaboration.
EURAXESS Africa contributed actively by clarifying participation modalities for African institutions and facilitating connections between prospective partners. Their engagement reinforced the importance of institutional guidance in navigating international research frameworks.
The broader implications extend beyond academia. Strong research systems support healthcare delivery, attract investment, and stimulate innovation-driven enterprise. For business leaders and investors, predictable funding pathways and institutional credibility create confidence within the innovation economy.
Policy leaders at the event emphasised the importance of sustained financing, regulatory clarity, and long-term coordination across sectors. Science and innovation were framed as central pillars of national competitiveness.
For Nigeria’s health and innovation community, the implications are significant. Stronger grant systems translate into stronger clinical trials. Clearer policy coordination accelerates the journey from research to real-world impact.
When science is positioned as economic infrastructure, its effects reach hospitals, laboratories, startups, and industry alike. The opportunity now lies in disciplined execution and sustained commitment.
